aripiprazole tablets

DRUG2 trials

Sponsors

Otsuka Pharmaceutical Development & Commercialization, Inc., Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Conditions

Acute SchizophreniaSchizophrenia

Phase 1

A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot

CompletedNCT01870999

Otsuka Pharmaceutical Development & Commercialization, Inc.Schizophrenia

Start: 2007-11-30End: 2008-10-31Updated: 2014-01-22

Phase 3

A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia

Not yet recruitingNCT06589817

Chengdu Kanghong Pharmaceutical Group Co., Ltd.Acute Schizophrenia

Start: 2024-10-31End: 2026-12-31Target: 376Updated: 2024-09-19